Principles and Strategies for Designing Best-in-Class Immuno-Oncology ADCs

from PharmaTalkRadio · host Conference Forum

About this podcast:This podcast dives deep into the fundamentals of antibody-drug conjugate design, specifically focusing on the selection of targeting antibodies, cytotoxic drugs, and linkers. Presenter Dr Deepa Pakianathan highlights key strategies for constructing ADCs and the critical differentiating features that enhance therapeutic efficacy and safety. For more information, go to IO360summit.com.

Episode metadata supplied by the publisher feed · Published Oct 24, 2025

Embed this episode

Attribution link and audio player

Ready to play

Principles and Strategies for Designing Best-in-Class Immuno-Oncology ADCs

0:00 17:35

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of PharmaTalkRadio?

This episode is 17 minutes long.

When was this PharmaTalkRadio episode published?

This episode was published on October 24, 2025.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this PharmaTalkRadio episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!